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As a wise chemist once said. "There is an important question that must be asked when
approaching any difficult project for the first time. and that question is. Why bother?"
-Creations ofFire
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Abstract
Nizatidine, N-[2-[[[2-[(dimethylamino)metbyl]-4-thiazolyl]methyl]thio]ethyl]-N'
methyl-2-nitro-l,l-ethenediamine (Axid"), has been investigated for its potential to act as a
host in guest-host complexes. Nizatidine binds with the guests through hydrogen bonding
and pi-pi interactions. Guest-host studies were conducted using fluorescence quenching,
calorimetry, NMR. and UVNisible experiments. The lowest energy conformation of
nizatidine is found to be U-shaped through theoretical calculations. Fluorescence
experiments indicated that tryptophan and pyridoxine had large association constants.
Further studies using calorimetry and NMR techniques concluded that no complexation had
occurred. Complexation experiments have been done to find guests that complex with
nizatidine. Caffeine, luminol, nicotinamide, phenylalanine, pyridoxine, pyrogallol, and
tryptophan were the guests used in this study.
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Introduction
Molecular recognition occurs when a host molecule recognizes and complexes with
a guest molecule. To form a complex, a host must have binding sites which contact and
attract the binding sites of guests without generating strong nonbonded repulsions. I
Complexes can be held together by hydrogen bonding, ion pairing, 1t acid to rt base
interactions, metal to ligand binding, van der Waals attractive forces, and solvent
reorganization.'
Molecular recognition is important in every aspect of life; as it controls cellular
functions, enzyme-substrate binding, and protein-DNA binding. Many investigations have
been conducted on large molecule hosts. Thus molecular recognition using large molecules
is finding increasing understanding. Few studies have been performed using small
molecules as hosts. The goal of this study is to understand the interactions involved in
guest host complexation and to predict tight binding for small molecule guest-host
complexes.
Entropy plays an significant role in guest-host complexation. As the guest and host
bind the entropy of the complex will decrease. Cram's principles indicate that the host
should be arranged in such a way that little conformational change is necessary to create
interactions between the guest and the host. I Thus functional groups should be in a fixed
position so that little conformational changes need to be done to align the guest and the host
minimizing the unfavorable entropy change.
Hydrogen bonding plays an important role in guest-host complexation.' A
hydrogen bond is the most common non-covalent interaction.' Hydrogen bonds occur
when a hydrogen atom is covalently bonded to a nitrogen, oxygen, or other electronegative
atom and non-covalently bonds with another electronegative atom less a

3A away.

position of the hydrogen atom relative to the hydrogen acceptor is important.

The
This

directionality is due to the geometry of the lone pairs participating in the bond (Figure 1).

o

.-0---
Figure 1: Direction of lone pairs involved in hydrogen bonding.
Oxygen has tetrahedral geometry. Thus the lone pairs are fI:f> from the plane of the bond
that oxygen is forming with another atom. The hydrogen atom has to be able to be in the
plane with the lone pairs to form a strong bond. The planar requirement is also true with
nitrogen, which also has tetrahedral geometry with one lone pair. Since the lone pair is
located on top of the molecule, the hydrogen bond is formed from above the nitrogen.
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Sulfur has a lone pair in a p orbital that is perpendicular to the plane of the covalent bond
that it is forming with another atom.
Hydrogen bonding can occur intermolecularly and intrarnolecularly.' (Figure 2)
Provided that the molecule has enough degrees of freedom, a hydrogen bond can occur
within the molecule between a hydrogen and electronegative atom as mentioned above.
Hydrogen bonding in a flex..ible host will decrease the size of the cavity that a guest could
inhabit thus increasing and decreasing the likelihood of complexation. Hydrogen bonding
could also prearrange the host for better interactions, thus satisfying Cram's rule.

H-- O

o

~S

o

Figure 2: Intramolecular hydrogen bonding.
Another interaction that must be considered for the formation of complexes is
hydrophobic interaction. Polar compounds, which are soluble in water, are hydrophilic
while non-polar compounds are hydrophobic, and thus will not dissolve in water.
Hydrophilic! hydrophobic interactions play a role in complexation.

A host such as

cyclodextrin can have a hydrophilic exterior and a hydrophobic interior. Thus the host will
dissolve in water due to the hydrophilic wall around the molecule. Any hydrophobic guest
that can fit into the hydrophobic cavity will strongly complex with the host inside the cavity
(Figure 3).

OH

HO

Hydrophobic
Cavity
OH
OH
Figure 3: Hydrophiliclhydrophobic interaction.
It-lt

interactions also playa role in molecular conformation and molecular

recognition. These interactions are caused by electrostatic and Van der Waals interactions
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of 1t systems.' The two conformations in which 1[ systems can interact are face-face and
edge-face with the two

1[

systems between 4 and 5 Aapart (Figure 4).

~~

a
•a.

Figure 4: (a) Face-face

1[

b.

interactions, and (b) Edge-face

1[-1[

interactions.

Face-face interactions should not be possible due to the repulsion of the electrons in the 1t
systems.' However, face-face interactions can still occur, but they are a result of the

1[

system of one molecule interacting with the o-system of the other molecule.' This usually
results in the two

1t

systems being slightly offset (Figure 5).

Figure 5: Two 1t-systems skewed.
The distance for face-face

rt-rt

interactions is 3.4;\ between molecular planes while

the distance for edge-face 1[ interactions is 2A from the plane of the 1t system to the atom
which is bonded to the hydrogen."
Guest-host complexes are difficult to investigate because solvents interfere with the
interactions between the guest and the host. A majority of guest-host studies are done in
chloroform or DMSo4..H. 7 or at extreme pH. s However, biological guest-host interactions
occur in aqueous solution. The problem with studying guest-host complexes in water is
that many hosts are hydrophobic. Also water has the ability to form hydrogen bonds when
in solution with nitrogen or oxygen containing compounds.' This may result in
competition between the water and the host. The effects of hydrogen bonding due to water
must be overcome to form a complex.
Nizatidine, Cll~IN502S2' was used in this study because it can be contorted to be
the perfect host (Figure 6).

8

N

/

Figure 6: The structure of nlzatidine.
Nizatidine contains the following structures: the guanidine type fragment, a, is referred to
as the guanidine fragment in this paper, the thiazole, b, which contains the sulfur group,
the irnidizole ring, c, and the tertiary amine group, d. Nizatidine is a flexible molecule, thus
it is able to twist into many conformations to maximize the interactions between it and a
guest. Nizatidine also has many places where a guest could bind. Hydrogen bonding can
occur at nitrogen, oxygen, and sulfur atoms found throughout the backbone of Nizatidine.
Finally, Nizatidine is found in Axid" which is a readily available over the counter heartburn
medicine.

Molecular Recognition
Molecular recognition plays a central role in medicinal chemistry, particularly
enzyme substrate binding. A particular example of molecular recognition is the
complexation of a histamine with an H p H 2, or H 3 receptor. HI receptors are involved in
the contraction of muscle cells upon stimulation, H 2 receptors are involved in the secretion
of gastric acid, and H) receptors prohibit the release of some neurotransmitters.
The secretion of gastric acid by H 2 receptors results in heartburn, a common
affliction in adults." Since beanbum affects so many people, studies are being conducted
to find the most efficient H, antagonist possible to prevent the secretion of gastric acid.
Histamine binds to the H, receptor at two binding sites, which are the left-most sites in
figure 7. H 2 antagonists are designed to block the action of histamine by preferentially
binding to the enzyme. Nizatidine is an effective antagonist because it can bind to three
agonist binding sites and two additional sites that histamine can not reach, thus creating a
stronger complex (Figure 7).

9

NH 2

:::::HN~S~NANH2'
'L
""
II

II

II

u

't

__

N
II

II

II
II

Agonist Binding Sites

Antagonist Binding Sites

Figure 7: Schematic of an antagonist interacting with H, receptor sites.
There is no interaction between histamine and the third agonist binding
site. A flexible, longer molecule could bind at this site crealing a stronger
complex with the H 1 receptor.
H 2 antagonists were inspiration for this study. The properties of H, antagonists are
well known because of their pharmacological uses. They are water soluble, exhibit strong
binding in enzyme-drug complexes, are conformationally flexible, and readily available.
However, in most drug applications, the H, antagonist is the guest molecule. In this study,
an H 2 antagonist was chosen as the host molecule.
Nizatidine was chosen based on its potential to be a host for a wide range of small
molecules. Nizatidine possess basic character in its aliphatic sulfur and in the numerous
amine and imine groups present in the molecule. Also, sulfur acts as a soft base while
amine and imine groups act as bard bases. The imidazole ring, thiazole, and guanidine can
be involved in intra and intermolecular pi-pi interactions. The flexibility of nizatidine

allows it to have many different conformations thus allowing nizatidine to complex with
many different small guests
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Theory
Molecular Modeling
Computational methods were used to determine the potential for nizatidine to bind
to various guests. First. molecular mechanics geometry optimization calculations were

performed to determine the minimum energy conformation of nizatidine.
Molecular mechanics calculations minimize the potential energy of a molecule. The
energy involved is defined by a classical force field. These energy terms are bond stretch
energy, angle energy, dihedral energy, improper energy, Leonard-Jones energy, and
electrostatic energy. The sum of all of these terms is the total energy of the molecule.
Molecular orbital calculations predict the minimum energy conformation by changing the
bond length and angles. Semi-empirical and ab initio methods were used in this study.
The semi-empirical molecular orbital calculations used PM3 theory. Semi-empirical
calculations use parameters derived from experimental data to solve the Schodinger
equation. This approximate form of the Schodinger equation uses parameters that are
dependent on the chemical system. I I Ab initio theory uses no experimental parameters to
solve the Schodinger equation. These calculations are based on the laws of quantum
mechanics and on the values of a small number of physical constants. I I These constants
are the speed of light, the masses and charges of electrons and nuclei, and Planck's
constant.
Serni-empirical and ah initio calculations differ in their accuracy in calculating the
lowest energy conformation of a molecule. Semi-empirical calculations are relatively
inexpensive calculations and give a good approximation of the molecular conformation. On
the other hand, an ab initio calculation is time consuming, but gives an accurate description
of molecular conformation because it does not make as many approximations in its
calculations. Molecular mechanics calculations give a rough idea of the molecular structure
of the molecule, but molecular orbital calculations have to be done to fully understand
molecular interactions.

Complexation Studies
Numerous methods can be used to determine association constants of complexes.

In this study fluorescence, UVNisible, NMR, high performance liquid chromatography.
ion chromatography, and thermometric titration methods were all used to study the
complexation of nizatidine with various guests. The association constant for a guest-host
complex is calculated the following way :

Ka = [Guest-Host]/[Guest] [Host]

( 1)
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Fluorescence
Fluorescence occurs when an excited molecule returns to its ground state by
emitting a photon . The transition occurs when the molecule drops from the lowest
vibrational level of an electronic state to anyone of the vibrational levels of the ground
state. Fluorescence is more commonly found in compounds in which the lowest energy
transition is of a 7[~7[' type than in compounds where the lowest energy transition is of the
n-m' type." This is because 1t-41t' type transitions exhibit shorter average lifetimes
larger) so that deactivation processes that compete with fluorescence are less likely to

Cke

is

occur. The most intense fluorescence occurs in aromatic compounds. Compounds
containing aliphatic, alicyclic carbonyl structures, or highly conjugated double-bond
structures may also exhibit fluorescence on account of their low energy 7[' orbitals.
Two other pathways by which a molecule can lose its electronic energy are self
absorption and quenching. The former occurs when the wavelength of emission overlaps
an absorption peak. The fluorescence decreases as the emission traverses the solution and
is reabsorbed by other fluorescent molecules. Quenching is the result of collisions between
an excited molecule and another molecule.V Quenching can occur with guest-host
complexation (Figure 8).

heat

x

Figure 8: Energy release in fluorescence experiments. Molecule X is
excited to a higher energy state (X*) by light. x* can release energy by
fluorescence (path a), or by quenching witb molecule Y. Molecule Y is
either excited to a higher energy state or radiates heat when quenching
occurs."
The procedure and derivation of the association constant was taken from
Indiverno." Nizatidine is not fluorescent; however, varying the concentration of the host
and keeping the concentration of the guest constant, the association constant is calculated
by observing the change in the guest fluorescence. In the derivation, G will represent the
fluorescent guest., Nz will be the host nizatidine, and Nz-G will be the resulting complex.
The total fluorescence intensity, 4. is written as

:r,. == ID~b[x]<I>f
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where I, is the intensity of incident light, €,. is the molar extinction coefficient at the
absorbed wavelength A, b is the paLhJength of the sample, and [X] is the molar
concentration of X. The fluorescence quantum yield,

4lf' is the

fraction of molecules which

absorb light that re-emit a photon. If the fluorescence intensity is measured at a given
wavelength, A~, then the equation becomes
~;.-

::; IoE,.b[X141f Y).o
where Y).o is the fraction of the total emission intensity that occurs at the wavelength A".
If there are two species in the solution that both absorb and emit light, the total
fluorescence intensity is given by the sum of the individual fluorescences

r, ::; Io~Gb4lf.G[G]

+ Io~z-Gb4lf.Nz-G[Nz-G]

where [G] is the concentration of the guest and [Nz-G] is the concentration of the
nizatidine-guest complex.
For simplicity the following constants are defined

0G ::; Io~Gb4lf .G
~z-G ::; I oC?.N...ob4l f.Nz-G
Thus
(2)
At all times

[G]o::; [G] + [Nz-G]
[Nz], ::; [Nz] + [Nz-G]
where [G], and [Nz], are the total concentrations of the guest and nizatidine present in the
solution, while the quantities on the right hand side of the equation represent the
equilibrium concentrations of free guest , free nizatidine, and free guest-nizatidine complex.
Using the intensities above we can rewrite equations 1 and 2 as
K, ::; [Nz-G]/([G]o - [Nz-G])([Nzlo - [Nz-GJ)
(3)
If::; 0G([G]o - [Nz-GJ) + ~z.(j[Nz-G]
(4)
Rearranging equation 3 in terms of [Nz-G] results in the following equation
[Nz-Gl 2 - ([Gl + [NzL + ~.I)[Nz-G] + [Gl,,[Nzlo ::; 0
(5)
Solving for the roots and eliminating the root which leads to [Nz-G] > [GL results in
[Nz-G] ::; O.5{([Glo + [Nz]" + ~.I) - ([([Gl" + [Nz]o + Ka·I ) 2 - 4[Gl o[Nz]"l°.5} (6)
Substituting this equation into equation 4 results in the following expression
I, =0dGlo + O.5(ON%-G - 0G){([G]o + [Nz], + ~.l) - ([([Olo + [Nz]o + ~'1)2 - (7)
4[Gl o [Nz]o]O,5)
This equation was used to calculate a theoretical fluorescence intensity at a given {G], [Nz],
Ka, ~, and ~-G' The residual was calculated by subtracting the experimental I, from the

theoretical I,. Successive approximations

~ere

used to find the best match between

~,exp

and ~.lhoof by varying Ka, 0G' and ~z.G' From this Ka was determined.
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UVNisible
The

absocptio~ of ultraviolet

or visible radiation results from the excitation of

electrons.'! The absorption of ultraviolet or visible radiation occurs when a molecule, X, is
excited by a given wavelength of light

X + hv

---+ X'

This excited molecule only exists for a matter of nanoseconds. The excited molecule then
relaxes. The most common type of relaxation results in the excitation energy turning to
heat

X' ---+ M + heat
This process is the same as to the quenching process in fluorescence. The lifetime of the
excited molecule, X', is very short, so that its concentration at a given moment is
negligible.
The intensity of the absorbance peak is monitored as the guest is added to the
system. Then using equations 5, 6. and 7, the theoretical absorbance was calculated at a
given [G], [Nz], Ka,
quantum yield,

~~

n; and ~z.(j'

The n constants do not include the fluorescence

and the absorbance is measured instead of fluorescence intensity. The

residual was calculated by subtracting the experimental I, from the theoretical L, Successive
approximations were used to find the best match between IA,ap and IA,thcor by varying Ka,

n G• and~.

From this Ka was determined.

For the caffeine, nicotinamide, and phenylalanine studies the free host,

~z'

was

also used in the theoretical absorbance calculations. This is because ~ was absorbing at
the same wavelength as~. The modified equation used for the UV/visible experiments
was:

Ic = nG[G]o + O.5(~z.(j - 0G

- ~J {([Gl o + [NzL + ~.I) - ([([Gl o + [Nz]o + ~'1)2 ~
4[Gl o [N zlol°.s}

NMR
Peak positions in an 'H NMR spectrum are sensitive to the environment of the
hydrogen. When complexation occurs, the environment of the immediate hydrogens is
changed. As a result, a shift in peak position is a good indication that complexation is
occurring. The most dominate peak shifts will occur where the guest and host interactions
are the strongest, Due to these peak shifts, NMR studies were used to confirm that
complexation had occurred in the verification of the fluorescence and UV /visible studies.

Chromatography
High performance liquid chromatography (HPLC) and ion chromatography (K')
were used to confirm results found in the fluorescence and UV/visible studies. High
performance liquid chromatography separates compounds that are dissolved in solution.

14

The various components in the mixture pass through the column at different rates due to
differences in their partitioning behavior between the mobile liquid phase and the stationary

phase."
Ion chromatography is also a type of liquid chromatography, which it uses ion
exchange resins to separate atomic or molecular ions based on their interaction with the
resin . These two methods were also used to confirm the results found in fluorescence and
UV/visible studies.

Thermometric Titrations
Analytical and reaction enthalpy determinations are frequently studied using
thermometric titrations. 14.1$ Thermometric titrations are especially important in studying
protein and nucleic acid binding." This is because the enthalpy of formation of the
complex is easily determined by monitoring the temperature as a function of added reactant.

By performing various calculations, the association constant of the complex can be
determined.
The analytical sensitivity of thermometric titrations is linearly related to the
concentration." Therefore, in very dilute or concentra~ solutions the endpoint is well
defined. Thus if the reaction between nizatidine and a guest is monitored, the association
constant could be calculated and compared to those calculated in fluorescence and
UV/visible experiments.
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Experimental

Chemical Information
Potassium phosphate- Baker- Analyzed Reagent, Lot No. 6236
Sodium phosphate dibasic- Fisher Scientific Co., Lot No. 744058, CAS 7558-79-4
D-Sorbitol- Aldrich Chemical Co. No. 24,085-0, Lot No.4801LL, 99+%, Gold
Label
Pyridoxine Monohydrochloride (vitamin BJ- Sigma Chemical Company No
P-9755, CAS # 58-56-0, Lot NO. 61C-2050
Lrryptophan- United States Biochemical Corp., Lot No. 49530, CAS 73-22-3.
Caffeine- Nutritional Biochemical Corp., CAS 58-08-2
Luminol- (5-amino-2,3-dihydro-l ,4-phthalazinedione, sodium salt)- Sigma
Chemical Co. No. A-4685, Lot No.71H37861, CAS 200666-12-0
[3-cyclodextrin- Sigma Chemical Co., Lot No. 23F-0051
2-Napthalene sulfonic acid sodium salt- Acros Organics, Lot No. 116120. CAS
532-02-5
Sodium Acetate- Fisher Scientific, CAS 127-09-03
Glacial Acetic Acid- Fisher Scientific, Lot No. 723101
Nicotinamide- Aldrich Chemical Co., Lot No. 1911LH. 98%
L-phenyalanine- Acros, Lot No. 79912/1, CAS 63-91-2
Pyrogallol- J. T. Baker, Lot 90165

Guests
.Most of the guests used in this study were chosen from a previous study.' The
guests that were used in this study were caffeine, lurninol, nicotinamide, phenylalanine,
pyridoxine, and tryptophan. Pyrogallol was also found to complex to nizatidine based on
molecular calculations performed in this study. Pyrogallol was chosen from Aldrich based
on its 1t character and its terminal alcohol functionality.

Molecular Modeling
Silicon Graphics Indigo-2 XL
QuantalCHARMm. Molecular Simulations Inc. release 4.1.1. version 95.0320
Spartan, Wavefunction Inc. IRIX 5.2, version 4.0.3 GL
Cerius2.0, BIOSYMlMolecular Simulations Inc. revision 95.1207
Computational calculations in Quanta. Spartan, and Cerius2 were used to predict
the lowest energy conformation of nizatidine and to help in the search for guests. Models
were built in QuantalCHARMm and minimized using molecular mechanics force field
calculations using the steepest descents method. The energy gradient tolerance was lxlO' s
and the energy value tolerance was O.

Nizatidine was divided into fragments to determine the lowest energy conformation
of each fragment, The fragments were then joined together to build nizatidine. The lowest
energy conformation (Z2, Z.E, E2, or E,E) of the guanidine fragment of nizatidine was
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first determined through MOPAC calculations using PM3 theory. The minimized
guanidine was included with the rest of the nizatidine fragment for further calculations.
The minimjzed structure of nizatidine was imported into Spartan for an ab initio geometry
optimization with a 3-21G(*) basis set.
The final m.i..nimi.zed structure was imported into Cerius2.0 where methanols were

placed around nizatidine and MOPAC calculations using PMJ theory were run. The
purpose was to obtain a prediction about where the methanols would interact with
nizatidine. The QuantalCHARMm docking function was also used to predict the interaction
between nizatidine and methanols. The nizatidine/methanol structure was then imported
into Cerius2.0 where PM3 calculations were done to determine the energy of the resulting
complex. This structure was then imported into Spartan and ab initio calculations using 3
21 G(*) were run on the complex. . Nizatidine was then surrounded with benzene rings to
see jf 7t-7t interactions formed a stronger complex with nizatidine than hydrogen bonding.
The calculations mentioned above were also run on the uncomplexed guests.

Nizatidine Extraction
Nizatidine was extracted from Axid" capsules containing 75 mg nizatidine. The
contents of the pill were ground up with mortar and pestle and extracted with chloroform
through a 0.2 micron filter. The chloroform was then evaporated off and stock solutions of

nizatidine were prepared.

Fluorescence Spectroscopy
Fluorescence Spectrophotometer- Perkin Elmer model 650-1OS
Light Source- Perkin Elmer 150 Xenon Power Supply
Voltmeter- Hewlett Packard 3465A Digital Multimeter

All solutions were prepared in phosphate buffer (0.OO87M KH 2PO/ O.0302M
N~HP04;

pH 7.4) to maintain a constant pH in the system. All measurements were taken

using the voltmeter. fluorescence experiments were conducted on pyridoxine. tryptophan.
and luminal.
Fluorescence studies were first done using pyridoxine. Stock solutions of 1 roM
nizatidine (O.045g/135 mL) and 2 roM pyridoxine (O.08224g1200 mL) were prepared with
phosphate buffer. From the stock solutions. 25 rnL solutions were prepared with the
following concentrations:
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ratio [Pyridoxine] mM [Nizatidine] mM
0.01
0
1:00
0.01
0.001
10:01
0.01
0.002
5:01
2:01
0.01
0.005
O. J
1:10
0.01
0:01
0.01
0

Table 1: Concentrations of pyridoxine and nizatidine used in fluorescence
and UV/visible studies.
The optimum excitation and emission wavelengths were determined using a 0.0 1
mM pyridoxine solution and scanning for the optimum excitation wavelength while the
emission wavelength was set at zero . Then an emission scan was done at the previously
determined excitation wavelength. The excitation and emission wavelengths were 328 and
395 run respectively. The samples were measured in a quartz cuvette. The other
parameters were set as follows :
range
pm gain
response
mode
slit width

1
norm
nonn
norm
5nm

Table 2: Parameters used in fluorescence experiments.
A second fluorescence study with pyridoxine was conducted using the following
concentrations:
~doxine]mM

0 .01
0.01
0.01
0.01
0.01
0.01

[Nizatidine] mM
0
0.001
0 .002
0.005
0.01
0.01

Table 3: Concentrations of pyridoxine and nizatidine used in fluorescence
experiment.

In this study, the solutions were mixed by bubbling air through the cell. The solution was
allowed to equilibrate for five minutes while it was kept at 2SOC using a constant
temperature bath and a thermocirculator.
Standard addition fluorescence studies were also studied using the same
parameters. A solution containing 0.05/0.01 mM nizatidinelpyridoxine was added to a
solution of 0.01 roM pyridoxine in 0.1 mL increments. A second standard addition
experiment was done using a 0.02 mM nizatidine 0 .01 pyridoxine solution, and adding it to
0.01 roM pyridoxine in 0.1 mL aliquots,
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Tryptophan was also used in fluorescence complexation studies. The emission and
excitation wavelengths were determined in the same manner as pyridoxine wavelengths.
They were concluded to be 282 and 361 om respectively. The concentrations of the first
tryptophan trial were as follows:
[Tryptophan] mM [Nizatidine] roM
0.01
0
0 .01
0 .001
0 .01
0.002
0.01
0.01
0.01
0.1
0.01
0

Table 4: Concentrations of tryptophan and nizatidine used in fluorescence
and UV/vlsible experiments.
Standard additions experiments were also done using tryptophan. A solution of
0.01 mM nizatidine/O.Ol mM tryptophan was added to 0.01 rnM tryptophan in 0.2 mL
aliquots. In both tryptophan experiments, the same conditions were used as those in
pyridoxine including the constant temperature bath. A pipette was used to stir the solution
after each addition.
In a further study , a 0.01 mM nizatidine and 0.01 mM tryptophan solution was
added to 0.01 mM tryptophan in 0.1 mL aliquots and readings were taken immediately after
the solution had been mixed and two minutes after mixing had occurred. During the two
minutes, the shutter was closed and the cuvette was kept at 25°C. The same was done for a
solution containing 0.02 mM nizatidine and 0.01 mM tryptophan added to 0.0 I mM
tryptophan in 0.1 mL aliquots.
Fluorescence studies were also conducted using luminol. The excitation and
emission wavelengths were 395 and 430 run respectively. The other parameters were the
same as those used in pyridoxine. The sample was mixed using a plastic pipette. Standard
additions of a solution of 0.05 roM nizatidine and 0.01 roM luminol was added in 0.1 mL
aliquots to 0.01 rnM luminol.

UVlVisible Spectroscopy
UV/Visible Spectrophotometer- Hewlett Packard 8452A Diode Array
Spectrophotometer
Temperature Controller- Hewlett Packard 89090A
All solutions were prepared in phosphate buffer (pH 7.4) to maintain a constant pH
in the system. A Hewlett Packard Spectrophotometer was used for all measurements.
UV/Visible measurements were taken using sorbitol, pyridoxine, caffeine, phenylalanine,
and nicotinamide as guests.
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A 2.0 mM stock solution of sorbitol was prepared for the trials. From it, a 0.01

roM solution of sorbitol, and a 0.01 mM sorbitol with 0.01 rnM nizatidine solution was
prepared. A spectrum was taken of 1.5 mL 0.01 mM sorbitol solution in a quartz cuvette,
then after each 0.2 rnL aliquot of the sorbitol-nizatidine solution. After each aliquot, the
solution was mixed using a clisposable plastic pipette. The temperature controller kept the
cuvette at 25·C for the entire experiment.

The absorbency was measured at wavelengths

of 550 and 314.
The concentrations an d condi nons
.
0 f th eo ther guests were as f 0 II ows:
Wavelength
Guest
[Guest] mM [Guest]:[Nz] mM
0.0 1
0.01 :0.05
314
~lalanine
nicot inam ide
0.01
0.01 :0.05
314 258 216
272, 208
caffeine
0.01
0.01 :0.05

Table 5: Concentrations and wavelengths used in UV/visible experiments.
The concentration of the guest remained constant while the concentration of
nizatidine varied.
Other UVNisible experiments were done keeping nizatidine constant and changing

the concentration of the guest. These experiments were set up as shown:
Wavelength
[N z} mM J Nz]:[Guest] roM
Guest
caffeine
0.01
0.01:0.05
314,274,220,208
nicotinamide
314,262,204
0.01:0.05
0.01
phenylalanine
314,258,206
0.01:0.05
0.01
0.01:0.01
314,550
sorbitol
0.01 I

Table 6: Concentrations and wavelengths used in UV/visible experiments.
The concentration of nizatidine remained constant throughout the
experiments.
UVNisible studies were also done using tryptophan. The solutions used were those
prepared for the fluorescence studies. In all of the UV /Visible studies the cell was kept at

25°C. After each aliquot was added the solution was mixed using a disposable plastic
pipette.
NMR Spectroscopy
NMR- JEOL GSX400 Superconducting Magnet; JEOL Ff NMR Spectrometer;
GSX Dal.a System
Complexation studies were also attempted using solvent suppression. The NMR
was manually shimmed on a standard of ethylbenzene in D 6 -acetone. A 50 roM nizatidine
solution was prepared in phosphate buffer .(PH 7.4). The IH spectrum was obtained,
suppressing the water peak using homo-gated decoupling. A 50:50 roM
nizatidine.tryptophan solution was prepared and the IH spectrum of the solution was taken
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using the same methods. Finally, an IH spectrum was obtained using a 50 mM tryptophan
solution. Throughout the whole experiment, the temperature was kept at 27°C.
Nizatidine/caffeine complexation was also studied using the NMR. A 50 mM
nizatidine solution and a 50 roM caffeine solution were prepared and an IH spectrum was
taken of each solution. Then a 50:50 mM nizatidine:caffeine and a 50: 165 mM
nizatidine:caffeine solution were prepared and the IH spectra were taken.
High Performance Liquid Chromatography

Beckman lsocratic Chromatograph Model 330
Microsorb-MV 5 urn CI8 column
Stock solutions of tryptophan, sorbitol, and pyridoxine were prepared in phosphate
buffer (pH 7.4) to maintain a constant pH in the system. Phosphate buffer was also used
as the mobile phase. Standard solutions of 2xlO-3, 2x 10-4 , 2x 10.5 , 2xlO-6 were run to
determine the concentration needed to see a peak. After the desired concentrations of the
guests were determined, a 1:1 mixture of each guest and nizatidine was prepared using the
following concentrations:
[Guest] M
z M
2.ooE-05 2.00£.05
2.ooE-04 2.ooE-04

Table 7: Concentrations used in HPLC experiments.
A second experiment was done using a 20%:80% acetonitrile:phosphate buffer (pH
7.4) in the mobile phase. The pH of the phosphate buffer was also varied from 7.9 to 6.5.
A I: 10 acetonitrile.sodium acetate (pH 5.2) was also used for the mobile phase.
Ion Chromatography

Alltech 320 Conductivity Detector
Alltech 330 Column Heater
Alltech 325 HPLC Pump
A p-hydroxybenzoic acid buffer solution (pH 8.4+/- 0.02) was prepared and
filtered with a 0.2 micron filter . Pyridoxine.nizatidine solutions using reagent grade water
and filtered with a 0.2 micron filter. The concentrations were made as shown:
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[Pyridoxine] M [Nizatidine] M
2.00E-04
0
2.00E-Q4
2.00E-03
2.00E-04
6.00E-04
2.00E-04
2.00E-04

Table 8: Concentrations used for ion chromatography experiments.
The peaks were recorded using Strip Chart, a data acquisition program developed at Colby.
The temperature of the ceU was 35.0°C, the flow rate was 2.00 mUmin and the chart speed
was set at 0.5 sec/pt.
Thermometric Titration
Tronac lsoperibol Titration Calorimeter Model 458
A 5.0 mM nizatidine solution and a 2.5x 10- 2 roM tryptophan solutions were
prepared in phosphate buffer (pH 7.4) and allowed to equilibrate in a 25°C water bath. 2.0

mL of nizatidine was pipetted into the reaction vessel, and attached to the calorimeter. The
buret was filled with 2.5xlO·2 mM tryptophan. The thermometric titration was monitored
on a strip chart recorder. An additional study was done with 2.0 mL of 2x 10.2 mM
tryptophan as the host and titrating with 5.0 roM nizatidine.

22

R esult s

Molecular Modeling

Molecular orbital calc ulations were performed on the guanid ine fragment of
nizaiidine to dete rmine the lowest energy con formation (Figure 9).
J.
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d.

Figure 9: Guanidine fragments. (a) E,E conformation, (b) E,Z
conformation, (e) Z,Z conformation, and (d) Z,E conformation.
The Z.E conformation was determined to have the lowest energy (Table 9). This is
consistent with previousiy
I reporte d co nformations. )
Conformation Energy (kcaJJrnol) I Level
-293041.81
3-21G(*)
E.E
---293034.94
3-21G(*)
r - - E,Z
' -- " ~
-293035.12
3-21G(*)
Z.Z
- .
Z,E
-293047.35
3-21G(*)

Table 9: Conformational energies of the guanidine fragment.
The lowest energy conformation of nizatidine was determined using ah initio
molecular orbital calculations (Figure 10).
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F igur e 10: T h e lowest e n e r gy conformat ion of' niz atidine.
The calculation. predicted nizaudmc was Il-shaped with the thiazole ring anel the

imidazole/tluazol e fragments perpendicular to each other. HOMO and LL MO densities
were calculated showing the largest HOMO density centered around the guanidine and the
tertiary amine section while the largest LUMO density was centered around the guanidine
group. Electrostatic potential calculations concluded that the thiazolc, the nitrogen in the
imidazole ring. and the tertiary amine groups arc electron rich, the nitrogen of the
guanidine fragmen t arc electron poor. The oxygens of the guanidine fragment are electron
rich.
Using inexpensive molecular mechanics calc ulauons, initial predictions were made
for guest-he t complexation. Initially nizatidine wa urrou nded by methanols to determine
the interactions between the methanols and nizatidine (Figure 11).
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Figure 11: Methanol complexing with nizatidine.
Py rogallol was suggested as a good guest us ing se mi-empirical calculations Figure
12).

Figure 12: The preferred conformation of the nizatidine/pyrogallol
complex.
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Fluorescence

Tryptophan had the greatest fluorescence with an excitation of 290 11m and an
cmis: ion of 360 nm with a slit width of 5 nrn. The a. sociati on constant of the
nizatidinc/tryptophan co mplex was Ka = 9.8x102 Llmol (Figure l J).
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Figure 13: Flu orescence of a 0.01 rn M tr yptoph an s o lu t io n with s ta n da r d
additi on s of 0 .05 mM nizatidine/O.Ol mM tryptophan.

Many other guests were used in the fluorescence study. The optimum conditions
and the association constants are listed below:
Guest
Excitation (nm) Emission (nm) Slit Width (nm) Ka (U mol)
pyridoxine
:28
395
5
3.2 lx 10 P
caffeine
290
322
5
4.49x I O~
Table 10: Fluorescence parameters and as sociation constant s of th e
nlz a t id ine/gu es t compl ex.

The graph of the fluorescence intensity Ve L us the concentration of nizatidine for the
caffeine study is shown in figure 14.
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Figure 14: Fluorescence of a 0.01 rnivl caffeine solution with standard
additions of 0.05 mM nizatidine/O.Ol mM caffeine.
The fl uorc scencc spectra of lumina l contradicted earlier stud ies performed on the

nizatidine complexation.' In previous studies with luminol, Del'S csto concluded thar no
complexation had occurred between luminol and nizatid ine.' Ideal experimental conditions
for the trial resulted in an excitation wavelengt h of 395 nm and e rnis .ion wavel ength of 428
nm with a slit width of 5 nm, The association COIL tant of the niza ticl inelluminol complex
was K a = 2 . 0 7x l O~ Llmol (fi g ure 15).
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A 0.0 I

m ~l

tryptophan wuh O. I mL 31iquo is of 0.0 1/0 .0:2 mM

tryptophan/nizatidine resulted in an excitation wavelength of 284 nm and an emission
wavelength of 356 nm resulted when the ce ll equilibrated at 25"C for two minutes.
Readings were take n when the standard addIl ion was added. The association constant for
these readin gs was Ka = 4.l 7x 104 Llmo l (Figure 16). After the initial readings, the shutter
was close d and the cell equilibrated at 25°C for two minutes before the next reading was
taken. T he resulting association .onstant was Ka = 3.44 x 105 L'mol (Figure 17). These
two Ka values arc within expe rimental error.
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Figure 16: Fluorescence of a 0.01 mM tryptophan solution with standard
additions of 0.02 mM nizalidine/O.Ol mM tryptophan. Readings w ere taken
immediately after the standard addition.

0 _93

0.9l •
>,
z

c
~

0 .89 •
0 .87

0.,5
O. 3

••

.......

0 .8 1
0 .79
0.77
0 .75

a

0.000005

0.0000 1

. ' (ex p)
. ' ( fit)

0.000015

[Nizatidi ne ] M

Figure 17: Fluorescence of a 0.01 mM tryptophan solution with standard
additions of 0.02 mM nizalidine/O.Ol mivl tryptophan. Readings were taken
two minutes after the standard addition.

The guests and the ir Ka with nizatidine arc found in table 11. The se values we re
calculated by minim izing the square of the res iduals by ch angi ng

{lnz_G-

{lG'

and Ka.
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Ka (lJmol)
Guest
4.49xl<r
caffeine
luminol
2 .07x 10"
pyridoxine
3 .21xlO IJ
9.76x lQ3
tryptophan
tryptophan @ 25C initial
4.17x HI'
tryptophan @ 25C after 2 min. 3.44xlCP

Table 11: Association constants calculated for fluorescence experiments.

UVNisible
UV/Visible spectroscopy was used to confirm the results from fluorescence and to
study guests that did not fluoresce. Ka values were calculated by minimizing the square of
the residuals by changing ~.(j,~, and Ka, The nizatidine used to make the solutions
was very impure, which was not expected.' The concentration of the nizatidine had to be
treated as a variable and included in the successive approximations fitting procedure. The
fit concentrations produced a consistent value for ~ of around 55,000 Umol. However,
because of the uncertainty in this value, we could only determine the Ka to one significant
figure (fable 12).
Ka(Umol)
Guest
6xlO i l
caffeine
nicotinamide
9xlCP
phenylalanine
2xlO ll
4xlQ6
pyrogallol

Table 12: Association constants calculated for UV/visible experiments.
UV/visible spectra and graphs for the caffeine, nicotinamide, phenylalanine, and
pyrogallol are shown below (Figures 18-28).
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Figure 18: UV/visible spectra of 0.0110.05 mM nizatidine caffeine and 0.01
mM nizatidine. The upper trace is caffeinelnizatidine and the lower trace is
nizatidine.

-•

- -- - - - - - - - - - - - - - - - - - - - - - - - - - - - ---,

:l.C+91

....
-=

-"co'"

-."

-v-

11

2tU
l.-

0JUJ

'.)0

!itO

-

. _ ~£~_ c.~G.I._!;I
~~

000

_

Figure 19: UV/visible spectra of 0.01 mM caffeine with 0.1 mL aliquots of
0.05/0.01 mM nizatidine/caffeine.
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Figure 23: UV/visible spectra of 0.01 roM nicotinamide with 0.1 mL
aliquots of 0.0110.05 mM nicotinamidelnizatidine.
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Figure 24: UV/visible absorbance of 0.01 mM nicotinamide with 0.1 mL
aliquot s of 0.01/0.05 mM n i cof ina mi d e/nizat ld ine .
, . . . . - - - - - - - - - - - - - - - - - - - _.- .- - 
( .~I.

(1
o .~n:

•

a

G .!:O~ J

....""

.

1\

I

a

~

C'. :I:J772

!>O)

l..l<VC _ CtlG..l..ll
T.....

8X

:"00

ox

_

Figure 25: UV/visible spectra of 0.01 mM nizatidine and 0.05 mM
phenylalanine. The upper trace is phenylalanine and the lower tr ace is
nizatidine.
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Figure 26: Uv/visible spectra of 0.01 mM phenylalanine with 0.1 rnL
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Figure 27: UV/visible absorbance of 0.01 mM nizatidine with 0 .1 mL
aliquots of 0.0110.05 mM nizatidine/phenylalanine.
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Guest-host co mplexation was also studied via NMR. The lowest concentration of
nizatidinc that could still be detected by the NMR was 50 m~\'l (Figures 29 and 34).
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Figure 29: 'H spectrum of 50 mM nizatidine in phosphate buffer (p H 7.4).

1 he NMR spectra taken for the tryptophan complexation study arc shown in figure ' 30 and
31.

·1·········1······ ,

,

1\••••••

···1···· ,

a ..

1·········1···.. a.

Figure 30: 'H spectrum of 50 mM tryptophan in phosphate buffer (pH 7.4) .

.
Figure 31: IH spectrum of 50:50 mM nizatidine:tryptophao in phosphate
buffer (pH 7.4).
Nizatidine:caffeine complexation spectra are shown in figures 32, 33, 35, and 36.
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Figure 32: 'H spectrum of 50 mM caffeine in phosphate buffer (pH 7.4) .
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As shown in the 'H spectra above, there were no peak shifts in any of the NMR
studies. In the caffeine studies, all of the peaks were visible. The peaks from the N-H
peaks were very broad and small, thus this region had to blown up to see if there was any
shift in the peaks (Figure 34). The studies done with a 165 mMl50 roM caffeine/nizatidine
solution also showed no change in peak positions (Figure 36) .
In the tryptophan studies. there were also no peak. shifts. In these studies the N-H
peaks at 10.3 and 10.4 ppm were not seen. These studies indicating that no complexes
was forming with tryptophan and caffeine as guests .
High Performance Liquid Chromatography

No peaks were seen in the nizatidine/tryptophan complexation experiment. A
pyridoxine peak was seen . AI: 1 solution of nizatidine: pyridoxine was run and the peak
appeared in the same position as the uncomplexed pyridoxine peak.. A 10:1
pyridoxine.nizatidine solution was then run in the HPLC to see if a higher concentration of

pyridoxine was needed to shift the peak thus indicating complexation was occurring. This
peak was also in the same position as the peak resulting from 0.02 roM pyridoxine.
Ion Chromatography

A peak was seen for 0.02 roM pyridoxine. Solutions containing various
concentrations of nizatidine and 0.02 roM pyridoxine were run through the ion
chromatograph. These runs resulted in little or no change in the peak: height or peak
position (Tables 13 and 14).
Pyridoxine (M) Nizatidine (M) Time (sec) Height (Jls) Intergration
2.00E-04
130
0
136.96
969.92
1·2.00E-04
2.00E-02
131.5
139.84
1214.56
2.00E-04
9.00E-03
131
140.32
1069 .8
2.00E-04
5.00E-03
130
169.92
1401.76
2.00E-04
2.00E-03
130
1135 .2
132.16

Table 13: Experimental conditions and results for peak one of the ion
chromatography experiment.
Pyridoxine (M) Nizatidine (M) Time (sec) Height (us) Intergration
2.00E-04
39.36
441.64
0
229
2.00E-04
2.00E-02
229
472.92
35.36
2.00E-04
9.00E-03
229.5
37.92
510
2.00E-04
5.00E-03
229
467.96
40.96
2.00E-04
2.00E-03
228.5 I 40.96
466.4

Table 14: Experimental conditions and results for peak two of the ion
chromatography experiment.
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Titration Calorimetry
No thermal effects were observed., indicating that no complexation was occurring.
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Discussion
The guanidine group preferred the Z,E conformation. This conformation is favored
because it allows the fragment to remain in its planer structure thus permining conjugation
throughout the fragment. These findings correspond to those found previously by
DeISesto. 3 When the guanidine fragment was part of the nizatidine molecule, calculations
concluded that it remains in its planer Z,E conformation. Nizatidine was predicted to be U
shaped molecule with the two

1t systems

perpendicular to each other to minimize electron

repulsion.
Molecular mechanics and ab initio calculations were also used to predict whether or
not a guest would complex with nizatidine. A previous study indicated that the formation
of the complex was the result of H-bonding. Calculations done on the nizaridine:pyrogallol
complex indicate that pyrogallol prefers to complex to the guanidine chain and not the
middle of nizatidine as formerly thought.' The interactions where predominately hydrogen
bonding, as before.

In the UV/visible studies the concentration of nizatidine also became a variable.
This was because the extraction method used in this study did not result in pure nizatidine.
Therefore, the concentration of nizatidine was smaller than believed thus the actual
concentration was varied to provide me best curve fit.

In the UV/visible studies, nicotinamide, phenyalanine, pyrogallol, and caffeine all
had strong complexation with nizatidine. In the fluorescence studies, pyridoxine, caffeine,
luminol, and tryptophan all complexed with nizatidine.
The UV/visible and fluorescence studies both indicated that strong complexation
was occurring between caffeine and nizatidine. This was not confirmed in the NMR
studies. However, there may have not been a 1:1 ratio of nizatidine:caffeine since the
actual concentration of nizatidine was unknown. Therefore, the NMR studies may have
indicated that no complexation was forming because the concentration of nizatidine was so
small in comparison to caffeine. This can also explain why tryptophan showed strong
complexation with nizatidine in fluorescence studies, but NMR experiments concluded that
no complexation was occurring.
One problem with the NMR studies was that the N-H peaks found

at

10.45 and

10.30 ppm were either very broad and small or not visible at all . If the guest was binding
at the guanidine fragment then the most noticeable peak shift would be the two N-H peaks.
The caffeine:nizatidine spectrum was the only one that showed the two N-H peaks.
However, as mentioned above the peaks were very small and broad. Thus if the peaks did
shift a little when the nizatidine.caffeine complex was formed the shift was not discernible
to the naked eye due to the size and breadt? of the peaks. However, there should have

been some change in the position of the guest peaks when complexation occurred. The
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spectrum for both tryptophan and caffeine complexing with nizatidine indicated also no
change in position for any of the peaks in the guest molecule.
There was no indication of a complex forming during the NMR, HPLC, IC and
titration calorimetry experiments, while both fluorescence and UV/visible experiments
argue the formation of a complex.
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Summary
The purpose of this srudy was to investigate the complexation of nizatidine with
small guests in aqueous solution at a pH of 7.4. Nizaridine has the ability to form
hydrogen bonds no matter what orientation it is in. From calculations of nizatidine alone, it
was concluded that nizatidine prefers to have a If-shaped conformation with 1[-1[
interactions between the imidazole and guanidine fragments.
Cram's rule states that the atoms of a molecule will be spatially arranged in such a
way to maximize interactions both intramolecularly and intermolecularly. The If-shaped
conformation of nizatidine obeys Cram's rules of preorganization (Figure 10). However,
Cram's rule of preorganization does not playas large a role as expected in nizatidine.guest
complexation. The slightly opened U-shape of nizatidine does not allow for

1t-1t

intramolecular interactions since the distance between the two pi systems is greater then the
2-3A distance needed for 1t-1t interactions.
Calculations conclude that pyrogallol prefers to bind at the guanidine fragment.
Since pyrogallol binds to a terminal position of nizatidine, it is able to bind with nizatidine
no matter what the conformation of nizatidine. We thus conclude Cram's rule of
preorganization does not play a role in the formation of the pyrogallollnizatidine complex.

It may be possible that the conformation that we have predicted for nizatidine/pyrogaUol
complex is not the lowest energy conformation. The complex has many degrees of
freedom so it is impossible to conduct an complete search for the lowest energy
conformation.
The original intent of this study was to find guests that would bind to nizatidine

through both hydrogen bonding and

1[-1[

interactions. However, calculations indicate that

pyrogallol only complexes with nizatidine via hydrogen bonding. Searches need to be
conducted to find molecules that bind to nizatidine via hydrogen bonding and 1t-1t
interactions to see if both 1[-1t and hydrogen bonding will form a stronger complex with
nizaLidine.
Fluorescence and UV/visible experiments concluded that pyrogallol, caffeine,
tryptophan, nicotinamide, pyridoxine, and phenylalanine do form strong complexes with
nizatidine, thus concluding that nizatidine has the ability to act as a host and complex with
small guests.
Nizatidine needs to be extracted from Axid" differently in order to get a pure
sample. When this is done, NMR studies can be done on the above mentioned guests to
support the conclusion that strong complexation is occurring between all of the guests and
nizatidine. 20 NMR srudies also need to be done to support the conclusion that the guests
are binding at the guanidine fragment.
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